InsiderSignal.AI

InsiderSignal.ai

APGE - Apogee Therapeutics, Inc.

Insider Sale by Henderson Jane (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Henderson Jane, serving as CFO at Apogee Therapeutics, Inc. (APGE), sold 2,000 shares at $90.00 per share, for a total transaction value of $180,000.00. Following this transaction, Henderson Jane now holds 175,371 shares of APGE.

This sale represents a 1.00% decrease in Henderson Jane's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 16, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 17, 2026, 1 day after the trade was made.

Apogee Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Henderson Jane

Henderson Jane

CFO

Jane Pritchett Henderson is the Chief Financial Officer of Apogee Therapeutics, Inc. (NASDAQ: APGE), a role she has held since January 2023.[[1]](https://fintool.com/app/research/companies/CRGX/people/jane-pritchett-henderson)[[2]](https://www.ventustx.com/jane-pritchett-henderson/)[[5]](https://app.boardroomalpha.com/profiles/people/A1075078-JANE_HENDERSON)[[7]](https://www.apogeetherapeutics.com/people/jane-pritchett-henderson) A veteran life sciences finance executive, she brings more than two decades of healthcare investment banking and senior corporate finance experience to Apogee, overseeing the company’s financial strategy and capital markets activities.[[1]](https://fintool.com/app/research/companies/CRGX/people/jane-pritchett-henderson)[[2]](https://www.ventustx.com/jane-pritchett-henderson/) In addition to her Apogee role, she serves as an independent director on the boards of companies such as Akero Therapeutics and Ventus Therapeutics, reflecting her broader governance and strategic advisory experience across the biopharmaceutical sector.[[1]](https://fintool.com/app/research/companies/CRGX/people/jane-pritchett-henderson)[[2]](https://www.ventustx.com/jane-pritchett-henderson/) Before joining Apogee, Henderson held senior finance and corporate development positions at multiple biotechnology companies, including Invivyd (formerly Adagio Therapeutics), Turnstone Biologics, Voyager Therapeutics, Kolltan Pharmaceuticals, and ISTA Pharmaceuticals, where she led financing, M&A, and business development initiatives.[[1]](https://fintool.com/app/research/companies/CRGX/people/jane-pritchett-henderson)[[2]](https://www.ventustx.com/jane-pritchett-henderson/)[[6]](https://www.biospace.com/voyager-therapeutics-appoints-b-jane-pritchett-henderson-b-as-chief-financial-officer) Earlier in her career she spent roughly 20 years in healthcare investment banking, executing more than 95 mergers, acquisitions, and financing transactions in senior roles at firms such as HSBC, CIBC, Lehman Brothers, and Salomon Brothers.[[1]](https://fintool.com/app/research/companies/CRGX/people/jane-pritchett-henderson)[[2]](https://www.ventustx.com/jane-pritchett-henderson/) Henderson holds a B.S. in psychology from Duke University.[[1]](https://fintool.com/app/research/companies/CRGX/people/jane-pritchett-henderson)[[2]](https://www.ventustx.com/jane-pritchett-henderson/)[[4]](https://rocketreach.co/jane-henderson-email_3283523)[[7]](https://www.apogeetherapeutics.com/people/jane-pritchett-henderson)

View full insider profile →

Trade Price

$90.00

Quantity

2,000

Total Value

$180,000.00

Shares Owned

175,371

Trade Date

Thursday, April 16, 2026

5 days ago

SEC Filing Date

Friday, April 17, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Apogee Therapeutics, Inc.

Company Overview

No company information available
View news mentioning APGE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5725045

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime